IDiyas

For the Inventor, By the Inventor

Montvale, NJ, United States of America

Thomas H Claus

USPTO Granted Patents = 11

Average Co-Inventor Count = 4.2

ph-index = 6

Forward Citations = 98(Granted Patents)


Company Filing History:

goldMedal11 out of 3,580 
 
American Cyanamid Company
 patents

Years Active: 1989-1997

Loading Chart...
11 patents (USPTO):Explore Patents
1. 5606069 - .beta..sub.3 -adrenergic agents, benzodioxole dicarboxylates and their (1997-02-25),
2. 5480908 - .beta..sub.3 -adrenergic agents benzodioxole dicarboxylates and their (1996-01-02),
3. 5373020 - Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles (1994-12-13),
4. 5245053 - Substituted 5-(2-(2-aryl-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxoles (1993-09-14),
5. 5151439 - Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles (1992-09-29),
6. 5106867 - Method of increasing lean meat in edible animals (1992-04-21),
7. 5061727 - Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles (1991-10-29),
8. 4968790 - Antidiabetic phosphates (1990-11-06),
9. 4945158 - Antidiabetic phosphonates (1990-07-31),
10. 4943629 - Antidiabetic alpha-substituted phosphonates (1990-07-24),
11. 4814350 - Method of treating diabetes with (1989-03-21),

Title: Thomas H Claus: Innovator in Antiobesity and Antidiabetes Agents

Introduction

Thomas H Claus is a notable inventor based in Montvale, NJ (US). He has made significant contributions to the field of pharmacology, particularly in the development of antiobesity and antidiabetes agents. With a total of 11 patents to his name, Claus has established himself as a key figure in the industry.

Latest Patents

Among his latest patents are innovations related to beta-3 adrenergic agents and benzodioxole dicarboxylates. These inventions focus on antiobesity and antidiabetes beta-3 agonists, characterized by specific chemical formulas that are detailed in the patent specifications. His work aims to provide effective solutions for managing obesity and diabetes through advanced pharmacological methods.

Career Highlights

Thomas H Claus has had a distinguished career, primarily working with American Cyanamid Company. His research and development efforts have led to groundbreaking advancements in the treatment of metabolic disorders. Claus's dedication to innovation has positioned him as a leader in his field.

Collaborations

Throughout his career, Claus has collaborated with esteemed colleagues, including Vern G DeVries and Minu D Dutia. These partnerships have fostered a collaborative environment that enhances the development of new therapeutic agents.

Conclusion

In summary, Thomas H Claus is a prominent inventor whose work in antiobesity and antidiabetes agents has made a significant impact in the pharmaceutical industry. His contributions continue to influence the development of effective treatments for metabolic disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…